Lung
Beacon Medical Interchange
Status of TMB as a Biomarker in NSCLC & Clinical Utility of Negative Prognostic Factors
FEATURING
Jack West,
Charu Aggarwal
- 22 views
- March 30, 2020
Beacon Medical Interchange
Best Treatment First: Implications for Front - Loading Combinations in Lung Cancer
FEATURING
Jack West
- 200 views
- October 29, 2018
Beacon Medical Interchange
How do Patients with Advanced NSCLC on Daily Steroids Do on Immune Checkpoint Inhibitors?
FEATURING
Jack West
- 649 views
- October 29, 2018
- 7
Beacon Medical Interchange
FDA Approval of Dacomitinib for NSCLC - Is it the Gamechanger in the First-line Treatment?
FEATURING
Jack West
- 831 views
- October 29, 2018
- 7
Beacon Medical Interchange
Is Progression-Free Survival without Overall Survival Benefit Enough?
FEATURING
Jack West
- 263 views
- October 29, 2018
- 2
Beacon Medical Interchange
Small Trial Shows Big Risks of First Line Pembro to EGFR Mutation-Positive Patients
FEATURING
Jack West
- 11 views
- October 29, 2018
Beacon Medical Interchange
Nivo/Ipi Rx of Choice for Adv. NSCLC, PD-L1 Under 1%, High TMB? New CheckMate 227 Data
FEATURING
Jack West
- 43 views
- October 29, 2018
- 1
Beacon Medical Interchange
Practice Changing Positive Keytruda Trial : Chemo +IO had significant survival benefit for Advanced Squamous NSCLC (KEYNOTE-407)
FEATURING
Jack West
- 246 views
- October 29, 2018
- 1
Beacon Medical Interchange
KEYNOTE-042: Should Pembrolizumab Replace Chemo for Broader Population with Adv. NSCLC?
FEATURING
Jack West
- 1,926 views
- October 29, 2018
- 14
Beacon Medical Interchange
My Top 5 ASCO 2018 Abstracts in Advanced NSCLC
FEATURING
Jack West
- 7 views
- October 30, 2018
Beacon Medical Interchange
My Top 5 ASCO 2018 Abstracts in Stage I-III NSCLC, Small Cell Lung Cancer, & Mesothelioma
FEATURING
Jack West
- 26 views
- November 2, 2018
Beacon Medical Interchange
Local Therapy for Advanced NSCLC: Revising Outdated Principles for Selected Patients
FEATURING
Jack West
- 355 views
- November 2, 2018
- 1
Beacon Medical Interchange
Is Chemo the Key for EGFR Mutation-Positive NSCLC? The Data Too Good to Overlook
FEATURING
Jack West
- 9,961 views
- November 2, 2018
- 40
Beacon Medical Interchange
IMpower131: Role for Carbo/Nab-Paclitaxel/Atezolizumab Combo for Adv. Squamous NSCLC?
FEATURING
Jack West
- 11 views
- November 2, 2018
Beacon Medical Interchange
Nivo/Ipi vs. Chemo in High TMB Advanced NSCLC: Key Results from CheckMate 227
FEATURING
Jack West
- 744 views
- November 2, 2018
- 5
Beacon Medical Interchange
Are TMB and Nivolumab/Ipilimumab Ready for Clinical Use? Insights from CheckMate 227
FEATURING
Jack West
- 490 views
- November 2, 2018
- 4
Beacon Medical Interchange
KEYNOTE-189: Clinical Implications in Patients with Less Than 1% Tumor PD-L1 Expression
FEATURING
Jack West
- 19 views
- November 2, 2018
Beacon Medical Interchange
KEYNOTE-189: Clinical Implications in Patients with Low (1-49%) Tumor PD-L1 Expression
FEATURING
Jack West
- 7 views
- November 2, 2018
Beacon Medical Interchange
KEYNOTE-189: Clinical Implications for High Tumor PD-L1 Expression
FEATURING
Jack West
- 7 views
- November 2, 2018
Beacon Medical Interchange
Is Chemotherapy More Effective After Prior Immunotherapy?
FEATURING
Jack West
- 14 views
- November 2, 2018
Beacon Medical Interchange
New Insights on Acq. Resistance to Immune Checkpoint Inhibitors for NSCLC: Implications
FEATURING
Jack West
- 8 views
- November 2, 2018
Beacon Medical Interchange
Pembro + Chemo in Metastatic NSCLC - Key Summary of a Practice-Changing Trial Keynote-189
FEATURING
Jack West
- 244 views
- November 2, 2018
- 2
Beacon Medical Interchange
Chemo/Immunotherapy in Advanced Squamous NSCLC: What is the Impact of IMpower131?
FEATURING
Jack West
- 7 views
- November 2, 2018
Beacon Medical Interchange
Afatinib in Patients With Uncommon EGFR Mutations In NSCLC
FEATURING
Jack West
- 138 views
- November 2, 2018
- 1
Beacon Medical Interchange
How Should We Monitor Patients After Potentially Curative Lung Cancer Surgery?
FEATURING
Jack West
- 10 views
- November 2, 2018
Beacon Medical Interchange
Diminishing Returns after a Fixed Duration of Immunotherapy Treatment in Advanced NSCLC?
FEATURING
Jack West
- 5 views
- November 2, 2018
Beacon Medical Interchange
Is There Still a Value in Testing for PD-L1 Expression in Advanced NSCLC Today?
FEATURING
Jack West
- 6 views
- November 2, 2018
Beacon Medical Interchange
Better Communication Leads to Better Outcomes for Cancer Patients
FEATURING
Jack West
- 9 views
- November 2, 2018
Beacon Medical Interchange
Are Two Immunotherapy Agents Better than One? Was the MYSTIC Trial a Mistake?
FEATURING
Jack West
- 9 views
- November 2, 2018
Beacon Medical Interchange
Is Immunotherapy Ineffective for Driver Mutation-positive Advanced NSCLC?
FEATURING
Jack West
- 362 views
- November 2, 2018
- 2
Beacon Medical Interchange
Is Durvalumab Curing Patients or Just Treating Metastatic Disease Earlier?
FEATURING
Jack West
- 192 views
- November 2, 2018
Beacon Medical Interchange
Durvalumab (Imfinzi) FDA Approved for Stage III NSCLC: Standard of Care?
FEATURING
Jack West
- 10 views
- November 2, 2018
Beacon Medical Interchange
Has the KEYNOTE-189 Trial Defined a Clear Standard of Care in Metastatic NSCLC?
FEATURING
Jack West
- 11 views
- November 2, 2018
Beacon Medical Interchange
Is There a Better Lung Immunotherapy Biomarker than PD-L1?
FEATURING
Jack West
- 179 views
- November 2, 2018
- 1
Beacon Medical Interchange
Atezolizumab in First Line Metastatic NSCLC: Early Clinical Results from the IMpower150 Trial
FEATURING
Jack West
- 9 views
- November 2, 2018
Beacon Medical Interchange
Genomic Sequencing for All Solid Tumors: Where Will This Lead Us?
FEATURING
Jack West
- 485 views
- November 2, 2018
- 5
Beacon Medical Interchange
Dabrafenib/Trametinib for BRAF V600E Mutation-Positive Advanced NSCLC
FEATURING
Jack West
- 15 views
- November 2, 2018
Beacon Medical Interchange
Osimertinib as First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC?
FEATURING
Jack West
- 124 views
- November 2, 2018
Beacon Medical Interchange
Dacomitinib: Dark Horse EGFR TKI Charges into First Line Setting for Advanced NSCLC
FEATURING
Jack West
- 131 views
- November 2, 2018
Beacon Medical Interchange
Are PD-1/PD-L1 Immune Checkpoint Inhibitors Completely Interchangeable in Lung Cancer?
FEATURING
Jack West
- 129 views
- November 2, 2018
Beacon Medical Interchange
Will Immunotherapy Shift Treatment Balance for Borderline Resectable Stage III NSCLC?
FEATURING
Jack West
- 247 views
- November 2, 2018
Beacon Medical Interchange
Research Question or Standard of Care: The Barriers to Broad Adoption in Lung Cancer Care
FEATURING
Jack West
- 9 views
- November 2, 2018
Beacon Medical Interchange
Hyper-Progressive Disease on Immunotherapy in Advanced NSCLC
FEATURING
Jack West
- 115 views
- November 2, 2018
Beacon Medical Interchange
Tumor Mutational Burden in SCLC: A Valuable Immunotherapy Biomarker?
FEATURING
Jack West
- 507 views
- November 2, 2018
- 4
Beacon Medical Interchange
Chemo/Immunotherapy Data Increasingly Compelling with Additional Follow-Up in Patients With Advanced NSCLC
FEATURING
Jack West
- 8 views
- November 2, 2018
Beacon Medical Interchange
The FLAURA Trial: Practice-Changing Results for EGFR Mutation-Positive NSCLC
FEATURING
Jack West
- 198 views
- November 2, 2018
Beacon Medical Interchange
Immunotherapy in Stage III NSCLC: Practice-Changing Results of PACIFIC Trial
FEATURING
Jack West
- 15 views
- November 2, 2018
Beacon Medical Interchange
Early Returns on FLAURA Trial: Osimertinib as First Line Agent in EGFR Mut-Pos. NSCLC?
FEATURING
Jack West
- 7 views
- November 2, 2018
Beacon Medical Interchange
Immunotherapy in Locally Advanced NSCLC - PACIFIC Study Shows Durvalumab Improves Overall Survival
FEATURING
Jack West
- 63 views
- November 2, 2018
Beacon Medical Interchange
IMpower133: Is there Finally a New Standard of Care for Extensive Stage SCLC?
FEATURING
Jack West
- 571 views
- November 7, 2018
- 5
Beacon Medical Interchange
Updated Results on PACIFIC Trial: Revise Who Should Receive Consolidation Immunotherapy?
FEATURING
Jack West
- 431 views
- November 16, 2018
- 3
Beacon Medical Interchange
Long-Term Management on Immunotherapy for Advanced NSCLC: Insights from KEYNOTE-010
FEATURING
Jack West
- 600 views
- November 16, 2018
Beacon Medical Interchange
Pembrolizumab for PS2 Patients with Adv. NSCLC: Results of the PePS2 Trial
FEATURING
Jack West
- 12 views
- November 16, 2018
Beacon Medical Interchange
The IMpower132 Trial: Does This Change the Advanced NSCLC Landscape?
FEATURING
Jack West
- 13 views
- December 4, 2018
Beacon Medical Interchange
The MYSTIC Trial has Failed on OS in Advanced NSCLC: What Does and Doesn't This Tell Us?
FEATURING
Jack West
- 12 views
- December 4, 2018
Beacon Medical Interchange
OS for Local Ablative Therapy for Oligometastatic NSCLC: Does it Fit in Now?
FEATURING
Jack West
- 13 views
- December 10, 2018
Beacon Medical Interchange
Chemotherapy With or Without Immunotherapy in Stage IV Non-squamous NSCLC: Does a Positive Trial Change Management?
FEATURING
Jack West
- 164 views
- December 12, 2018
Beacon Medical Interchange
Nivolumab vs. Chemo in Relapsed SCLC (review of Checkmate-331 trial)
FEATURING
Jack West
- 181 views
- December 27, 2018
- 1
Beacon Medical Interchange
Top 5 Most Influential Trial Findings in Lung Cancer Management in 2018
FEATURING
Jack West
- 639 views
- January 3, 2019
- 3
Beacon Medical Interchange
What is the Optimal Duration for Immunotherapy in Responding Patients with Advanced NSCLC?
FEATURING
Jack West,
David Spigel
- 831 views
- September 6, 2019
- 8
Beacon Medical Interchange
Changes in Lung Cancer Management, Addressing Stigma, and the Rise of Online Patients
FEATURING
Joan Schiller,
Jack West
- 4 views
- September 6, 2019
Beacon Medical Interchange
Overcoming Barriers in Cancer Care Delivery, Smoking Cessation, and Lung Cancer Screening Globally
FEATURING
Gil Morgan,
Jack West
- 20 views
- September 24, 2019
Beacon Medical Interchange
Weighing Clinical Significance of New Clinical Trial Results With Immunotherapy in Advanced Stage NSCLC
FEATURING
Jack West,
Corey Langer
- 537 views
- September 24, 2019
- 2
Beacon Medical Interchange
Chest CT Screening and Pulmonary Workups in Lung Cancer Beyond Tertiary Care Centers
FEATURING
Jack West,
Jed Gorden
- 262 views
- September 24, 2019
- 3
Beacon Medical Interchange
Why is Broader FDA Approval of First Pembrolizumab Monotherapy (KEYNOTE-042) Invitation to Inferior Care in Advanced NSCLC?
FEATURING
Jack West
- 1,236 views
- September 24, 2019
- 9
Beacon Medical Interchange
Current Practice & Challenges in Execution of Genomic Testing in Advanced NSCLC
FEATURING
Jack West,
Gregory Riely
- 313 views
- September 24, 2019
- 1
Beacon Medical Interchange
Critical Review of Combining Radiation with Immunotherapy in Advanced NSCLC
FEATURING
Jack West
- 1,010 views
- September 24, 2019
- 7
Beacon Medical Interchange
Open Questions in Radiation Oncology Care: From Proton Beam Radiation to SBRT for Oligometastatic NSCLC
FEATURING
Jack West,
David Palma
- 82 views
- November 6, 2019
- 1
Beacon Medical Interchange
Immunotherapy-Based Options for NSCLC: How to Decide Which Approach to Choose?
FEATURING
Jack West,
Charu Aggarwal
- 11 views
- June 1, 2020